• Please log in or register to access this feature.

SYSTEMATIC REVIEW

You have free access to this content

Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease

  1. B. Guo1,*,
  2. C. Harstall1,
  3. T. Louie2,
  4. S. Veldhuyzen van Zanten3,
  5. L. A. Dieleman3

Article first published online: 23 FEB 2012

DOI: 10.1111/j.1365-2036.2012.05033.x

Issue

Alimentary Pharmacology & Therapeutics

Alimentary Pharmacology & Therapeutics

Volume 35, Issue 8, pages 865–875, April 2012

Additional Information

How to Cite

Guo, B., Harstall, C., Louie, T., Veldhuyzen van Zanten, S. and Dieleman, L. A. (2012), Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Alimentary Pharmacology & Therapeutics, 35: 865–875. doi: 10.1111/j.1365-2036.2012.05033.x

Author Information

  1. 1

    Institute of Health Economics, Edmonton, Alberta, Canada

  2. 2

    Departments of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada

  3. 3

    Division of Gastroenterology, University of Alberta, Edmonton, Alberta, Canada

*Correspondence to:
Dr B. Guo, Health Technology Assessment Unit, Institute of Health Economics, 10405-Jasper Avenue, Edmonton, Alberta, CanadaT5J 3N4.
E-mail: bguo@ihe.ca

  1. This uncommissioned systematic review article was subject to full peer-review.

Publication History

  1. Issue published online: 21 MAR 2012
  2. Article first published online: 23 FEB 2012
  3. Manuscript Accepted: 27 JAN 2012
  4. Manuscript Revised: 25 JAN 2012
  5. Manuscript Revised: 8 JAN 2012
  6. Manuscript Received: 19 DEC 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (153K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lawrence J. Brandt, Olga C. Aroniadis, An overview of fecal microbiota transplantation: techniques, indications, and outcomes, Gastrointestinal Endoscopy, 2013,

    CrossRef

  2. 2
    Paul J. Collini, Ed Kuijper, David H. Dockrell, Clostridium Difficile Infection in Patients with HIV/AIDS, Current HIV/AIDS Reports, 2013,

    CrossRef

  3. 3
    Geom Seog Seo, Clostridium difficileInfection: What's New?, Intestinal Research, 2013, 11, 1, 1

    CrossRef

  4. 4
    Nuntra Suwantarat, David A. Bobak, Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?, Current Infectious Disease Reports, 2013, 15, 2, 101

    CrossRef

  5. 5
    Zain Kassam, Christine H Lee, Yuhong Yuan, Richard H Hunt, Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis, The American Journal of Gastroenterology, 2013, 108, 4, 500

    CrossRef

  6. 6
    E.O. Petrof, E.C. Claud, G.B. Gloor, E. Allen-Vercoe, Microbial ecosystems therapeutics: a new paradigm in medicine?, Beneficial Microbes, 2013, 4, 1, 53

    CrossRef

  7. 7
    Gergely György Nagy, Csaba Várvölgyi, Zoltán Balogh, Piroska Orosi, György Paragh, Módszertani ajánlás a Clostridium difficile fertőzéshez asszociált hasmenés széklettranszplantációval történő kezeléséhez, Orvosi Hetilap, 2013, 154, 1, 10

    CrossRef

  8. You have open access to this content8
    Pieter Van den Abbeele, Willy Verstraete, Sahar El Aidy, Annelies Geirnaert, Tom Van de Wiele, Prebiotics, faecal transplants and microbial network units to stimulate biodiversity of the human gut microbiome, Microbial Biotechnology, 2013, 6, 3
    Direct Link:
  9. You have free access to this content9
    E. Mattila, P. Arkkila, P. S. Mattila, E. Tarkka, P. Tissari, V.-J. Anttila, Rifaximin in the treatment of recurrent Clostridium difficile infection, Alimentary Pharmacology & Therapeutics, 2013, 37, 1
    Direct Link:
  10. 10
    Fergus Shanahan, The colonic microbiota in health and disease, Current Opinion in Gastroenterology, 2013, 29, 1, 49

    CrossRef

  11. 11
    Gergely György Nagy, Csaba Várvölgyi, György Paragh, Életet veszélyeztető, terápiarefrakter Clostridium difficile fertőzés okozta pseudomembranosus colitis sikeres kezelése széklettranszplantációval, Orvosi Hetilap, 2012, 153, 52, 2077

    CrossRef

  12. 12
    N. M. Joshi, L. Macken, D. S. Rampton, Inpatient diarrhoea and Clostridium difficile, Clinical Medicine, 2012, 12, 6, 583

    CrossRef

  13. 13
    Maya Balakrishnan, Martin H. Floch, Prebiotics, probiotics and digestive health, Current Opinion in Clinical Nutrition and Metabolic Care, 2012, 15, 6, 580

    CrossRef

  14. You have free access to this content14
    J. L. Anderson, R. J. Edney, K. Whelan, Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease, Alimentary Pharmacology & Therapeutics, 2012, 36, 6
    Direct Link:
  15. 15
    Fergus Shanahan, The Colonic Microbiota and Colonic Disease, Current Gastroenterology Reports, 2012, 14, 5, 446

    CrossRef

  16. 16
    Michelle D Cairns, Richard A Stabler, Nandini Shetty, Brendan W Wren, The continually evolvingClostridium difficilespecies, Future Microbiology, 2012, 7, 8, 945

    CrossRef

  17. 17
    Jean Carlet, The gut is the epicentre of antibiotic resistance, Antimicrobial Resistance and Infection Control, 2012, 1, 1, 39

    CrossRef

  18. 18
    Harry J. Flint, Karen P. Scott, Petra Louis, Sylvia H. Duncan, The role of the gut microbiota in nutrition and health, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 10, 577

    CrossRef

View Full Article (HTML) Get PDF (153K)